The Impact of Ayahuasca on Suicidality: Results From a Randomized Controlled Trial.
ayahuasca
novel intervention
psychedelics
randomized controlled trial
suicidality
Journal
Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923
Informations de publication
Date de publication:
2019
2019
Historique:
received:
24
07
2019
accepted:
15
10
2019
entrez:
5
12
2019
pubmed:
5
12
2019
medline:
5
12
2019
Statut:
epublish
Résumé
Suicide is a major public health problem. Given increasing suicide rates and limitations surrounding current interventions, there is an urgent need for innovative interventions for suicidality. Although ayahuasca has been shown to target mental health concerns associated with suicidality (i.e., depression and hopelessness), research has not yet explored the impact of ayahuasca on suicidality. Therefore, we conducted secondary analyses of a randomized placebo-controlled trial in which individuals with treatment-resistant depression were administered one dose of ayahuasca (
Identifiants
pubmed: 31798447
doi: 10.3389/fphar.2019.01325
pmc: PMC6878725
doi:
Banques de données
ClinicalTrials.gov
['NCT02914769']
Types de publication
Journal Article
Langues
eng
Pagination
1325Informations de copyright
Copyright © 2019 Zeifman, Palhano-Fontes, Hallak, Arcoverde, Maia-Oliveira and Araujo.
Références
J Psychopharmacol. 2008 Aug;22(6):603-20
pubmed: 18593734
BMJ Open. 2013 Jun 28;3(6):null
pubmed: 23811172
Int J Neuropsychopharmacol. 2017 Sep 1;20(9):698-711
pubmed: 28525587
J Psychopharmacol. 2016 Dec;30(12):1181-1197
pubmed: 27909165
Cell Rep. 2018 Jun 12;23(11):3170-3182
pubmed: 29898390
J Psychopharmacol. 2018 Jul;32(7):749-755
pubmed: 29807492
Curr Drug Abuse Rev. 2013 Mar;6(1):30-42
pubmed: 23627784
Transl Psychiatry. 2015 Feb 24;5:e516
pubmed: 25710122
J Clin Psychol. 2015 Aug;71(8):778-91
pubmed: 26192914
Front Psychiatry. 2018 Jul 03;9:293
pubmed: 30018574
Front Psychol. 2014 Jun 19;5:613
pubmed: 24994990
Arch Gen Psychiatry. 1996 Dec;53(12):1145-52
pubmed: 8956681
Am J Psychiatry. 2016 Mar 1;173(3):215-8
pubmed: 26926127
J Clin Psychiatry. 2007 Jul;68(7):1062-70
pubmed: 17685743
Eur J Epidemiol. 2016 Apr;31(4):337-50
pubmed: 27209009
Nat Rev Neurosci. 2010 Sep;11(9):642-51
pubmed: 20717121
Pharmaceuticals (Basel). 2010 Aug 30;3(9):2861-2883
pubmed: 27713380
J Clin Psychiatry. 2009 Aug;70(8):1069-77
pubmed: 19758520
Psychol Med. 2003 Apr;33(3):395-405
pubmed: 12701661
J Clin Psychopharmacol. 2016 Feb;36(1):77-81
pubmed: 26650973
J Clin Psychiatry. 1999;60 Suppl 2:104-10; discussion 111-6
pubmed: 10073397
Curr Psychiatry Rep. 2013 Jan;15(1):335
pubmed: 23250816
Acta Psychiatr Scand. 2005 Oct;112(4):302-9
pubmed: 16156838
Br J Psychiatry. 2018 Mar;212(3):148-154
pubmed: 29436321
Psychopharmacology (Berl). 2019 Feb;236(2):573-580
pubmed: 30406413
Am J Psychiatry. 2005 May;162(5):977-82
pubmed: 15863801
Am J Psychiatry. 2000 Apr;157(4):601-8
pubmed: 10739420
Am J Prev Med. 2014 Sep;47(3 Suppl 2):S195-203
pubmed: 25145739
PLoS Med. 2009 Aug;6(8):e1000123
pubmed: 19668361
Arch Gen Psychiatry. 1996 Dec;53(12):1155-62
pubmed: 8956682
Ment Health Clin. 2019 Jan 4;9(1):48-60
pubmed: 30627504
JAMA. 2004 Jul 21;292(3):338-43
pubmed: 15265848
Psychopharmacology (Berl). 2006 Aug;187(3):268-83; discussion 284-92
pubmed: 16826400
Br J Psychiatry. 1979 Apr;134:382-9
pubmed: 444788
Front Pharmacol. 2018 Mar 20;9:224
pubmed: 29615905
Depress Anxiety. 2014 Apr;31(4):335-43
pubmed: 24668760
Psychopharmacology (Berl). 2018 Feb;235(2):399-408
pubmed: 29119217
Lancet Psychiatry. 2016 Jul;3(7):646-59
pubmed: 27289303
Expert Rev Clin Pharmacol. 2018 Sep;11(9):889-902
pubmed: 30102078
J Psychopharmacol. 2015 Mar;29(3):280-8
pubmed: 25586402
J Consult Clin Psychol. 2000 Jun;68(3):371-7
pubmed: 10883553
Am J Med Genet C Semin Med Genet. 2005 Feb 15;133C(1):13-24
pubmed: 15648081
Bipolar Disord. 2006 Oct;8(5 Pt 2):625-39
pubmed: 17042835
BMJ Open. 2017 Sep 21;7(9):e016025
pubmed: 28939573
J Clin Psychiatry. 2009 Jan;70(1):19-24
pubmed: 19026258
Lancet Psychiatry. 2016 Jul;3(7):619-27
pubmed: 27210031
Expert Opin Pharmacother. 2016 Dec;17(17):2273-2279
pubmed: 27690663
Psychopharmacology (Berl). 2016 Mar;233(5):823-9
pubmed: 26612618
J Ethnopharmacol. 2007 Jul 25;112(3):507-13
pubmed: 17532158
Eur Psychiatry. 2010 Jun;25(5):260-3
pubmed: 20451355
Psychol Med. 2019 Mar;49(4):655-663
pubmed: 29903051
J Affect Disord. 2013 Jan 10;144(1-2):72-8
pubmed: 22858216
J Psychiatr Res. 2015 Sep;68:68-73
pubmed: 26228403
Psychol Rev. 1990 Jan;97(1):90-113
pubmed: 2408091
Curr Neuropharmacol. 2019;17(2):108-128
pubmed: 29366418
Biol Psychiatry. 2009 Sep 1;66(5):522-6
pubmed: 19545857
Pharmacogenomics. 2011 Mar;12(3):365-77
pubmed: 21449676
Am J Psychiatry. 2006 Jan;163(1):41-7
pubmed: 16390887
Curr Opin Psychiatry. 2018 Jan;31(1):69-73
pubmed: 29028643
Suicide Life Threat Behav. 1986 Summer;16(2):198-222
pubmed: 3529513
Depress Anxiety. 2019 Apr;36(4):321-329
pubmed: 30466148
J Pers Disord. 2010 Dec;24(6):763-72
pubmed: 21158598
BMJ. 2009 Aug 11;339:b2880
pubmed: 19671933
J Psychopharmacol. 2016 Dec;30(12):1165-1180
pubmed: 27909164
J Psychiatr Res. 1995 Jan-Feb;29(1):43-50
pubmed: 7629754
JAMA Psychiatry. 2017 Jan 1;74(1):9-10
pubmed: 27784055
Neurosci Biobehav Rev. 2017 Jun;77:232-236
pubmed: 28342764
Neurobiol Stress. 2018 Sep 21;9:166-175
pubmed: 30450382
Am J Psychiatry. 2012 Jun;169(6):560-3
pubmed: 22684591
Neuropsychopharmacology. 2002 May;26(5):634-42
pubmed: 11927188
Braz J Psychiatry. 2015 Jan-Mar;37(1):13-20
pubmed: 25806551
Am J Psychiatry. 2018 Feb 01;175(2):150-158
pubmed: 28969441
Psychiatry Res. 2015 Mar 30;226(1):361-7
pubmed: 25661531
Psychopharmacology (Berl). 2018 Oct;235(10):2979-2989
pubmed: 30105399
Int J Neuropsychopharmacol. 2011 Sep;14(8):1127-31
pubmed: 21557878
Psychol Med. 2017 Oct;47(14):2438-2449
pubmed: 28478783
J Psychopharmacol. 2018 Dec;32(12):1385-1391
pubmed: 30255717
J Affect Disord. 2012 Feb;136(3):398-404
pubmed: 22154567